popular wires

When sovereigns start to shift into an investment theme, it's time to understand both the theme and its variations

There is a growing realisation in markets that the traditional blueprint implemented since the GFC, may not unfold as expected this time. So how do you adapt your...

Last week, I penned the first part of this wire on why residential real estate is nowhere near as good a growth investment as many investors think, and I highlighted...

The flaw with renewable energy, the case for nuclear power as an alternative, and one stock we own to get exposure to this theme.

Get up to date on overnight market activity and the big events for the day.

Learn about the options available for generating passive income with ETFs, plus a popular strategy for investors in draw-down.

James Cooper explains why junior mining stocks are primed for recovery... Now is the time to position for this emerging secular bull market

This interview was originally published on October 9, 2023

Some commentators, pointing to the price to earnings (P/E) ratio for major indices like the S&P500, argue the next decade will be terrible for equities. Are they...

...and is generating strong returns for shareholders while doing it.

Tina Turner wasn’t the only Tina to die in 2023. The TINA that drove more than a decade of rising equity prices is dead, too. With interest rates near zero, commercial...

NovaPort’s Tim Binsted outlines the bull case for Mondelphous, which includes dividends, quality management, and a strong balance sheet.

With default rates on the rise, investors are understandably questioning what to do with their credit investments.

The daily Match Out for Monday 16 October 2023 with James Gerrish of Market Matters.

Get up to date on overnight market activity and the big events for the day.

There has been no shortage of news flow around Qantas (ASX: QAN) in recent weeks. Most of it negative – the ACCC instigated charges around selling cancelled flights,...

A flood of new global sovereign debt will affect market dynamics.

While markets appear to be faring relatively well so far in FY24, compared with the first half of FY23, a major economic downturn for our global economy could have a...

In this edition of the Movers & Shakers for Pharma & Biotech, we highlight 5 stocks that were on the move in September. Biotron Limited (ASX: BIT) Bitron shares were...

New research indicates there are 5 pathways common to the few that shoot the lights out of total shareholder return over a 10 year period